QantX
  • Home
  • Invest
  • Team
  • Strategy
  • Portfolio
  • News
  • Contact
  • Investor Portal
Select Page
QantX leads £600K investment round to speed up innovation in the quantum industry

QantX leads £600K investment round to speed up innovation in the quantum industry

by Hannah Beatrice | Nov 18, 2024 | Innovation, Portfolio

QantX has led a £600K investment round for Light Trace Photonics – a leading innovator in the integrated photonics industry – to help engineers in the quantum industry get their products to market quicker. We met with Jake Biele, Co-Founder at Light Trace...
QantX Spearheads £3m Investment for Innovative Cancer Screening Technology

QantX Spearheads £3m Investment for Innovative Cancer Screening Technology

by Harry | Oct 8, 2024 | Healthcare, Portfolio

Xgenera has secured £3m in funding, with investment led by QantX alongside a substantial £2.5m grant from the National Institute for Health and Care Research (NIHR). This investment marks a pivotal advancement in cutting-edge tumour detection methods. Dr. Andy...
Climate-i awarded £25k to tackle gas emissions

Climate-i awarded £25k to tackle gas emissions

by Hannah Beatrice | Oct 7, 2024 | Climate, Innovation Prize, Portfolio

The Blavatnik Prize for Innovation is a £1m prize fund awarded by QantX to pre-investment startups, providing up to £50,000 in non-dilutive funding and guidance from the QantX team. The prize supports businesses to unlock commercial barriers to their innovative...
Portfolio company Neuronostics raise over £2M in oversubscribed seed round

Portfolio company Neuronostics raise over £2M in oversubscribed seed round

by Harry | Apr 5, 2024 | Portfolio

SENISCA secures additional £3.7 million financing to support rapid development of senotherapeutic platform to treat age-related disease

SENISCA secures additional £3.7 million financing to support rapid development of senotherapeutic platform to treat age-related disease

by Harry | Mar 27, 2024 | Portfolio

iFAST Diagnostics raise £2M to track and treat antibiotic-resistant bugs

iFAST Diagnostics raise £2M to track and treat antibiotic-resistant bugs

by Harry Alexander | Feb 16, 2023 | Healthcare, Portfolio

Headline: Rapid diagnostic technology spun out from the University of Southampton can identify antibiotic resistance 10x faster than current gold standards Working closely with UKHSA at the world-leading microbiology labs in Porton Down to demonstrate clinical...
« Older Entries

Latest Posts

  • SENISCA: treating age-related diseases with ground-breaking science
  • Lutra Health: integrating community and hospital eyecare
  • QantX leads £600K investment round to speed up innovation in the quantum industry
  • Supporting the Full Innovation Stack: From Lab Discovery to Global Impact
  • QantX partners with the SETsquared Partnership universities on new £300m investment vehicle

enquiries@qantx.co.uk  

Investor Area

QantX (Reference number: 954072) is an Appointed Representative of Kin Capital Partners LLP (FRN: 656789). Kin Capital Partners LLP (trading as Kin Fund Services) is authorised and regulated by the Financial Conduct Authority.

© 2022 QantX. All rights reserved. Cookie Policy | Privacy Policy

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkPrivacy policy